RO5093151
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for RO5093151, covering 2016-07-28 to 2018-03-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT). [Phase 1]